Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Generics Use Rate by Far the Highest in Okinawa Prefecture
November 2, 2009
- Hatoyama Administration to Change Medical Expenditure Curtailment Policy
November 2, 2009
- Kyowa Kirin Transfers Neu-Up to Yakult
November 2, 2009
- Korosho to Issue Guidance for Transmission of Safety Information
November 2, 2009
- Medipal Ties Up with China's Largest Drug Wholesaler
November 2, 2009
- Bridion Recommended for Approval
November 2, 2009
- Terumo's Drug-Saving FN Syringe Approved in 3 Months
November 2, 2009
- 35 Products Approved Including Januvia/Glactiv -2-
November 2, 2009
- JMA to Reconsider Its Relationship with LDP
November 2, 2009
- New Gov't Will Continue to Promote Use of Generics: Mr Isobe
October 26, 2009
- Global Pharmaceutical Market to Grow 4-6% in 2010: IMS Health
October 26, 2009
- Biosimilars to Save 8.1 Billion Euro by 2020 in Germany
October 26, 2009
- BUSINESS NEWS IN BRIEF
October 26, 2009
- Sales of OTC Drugs Increase in Aug. for the First Time in 3 Months: Crecon
October 26, 2009
- Korosho to Stop Use of Add'l ¥85.4 Bil. in FY2009 Supplementary Budget
October 26, 2009
- 4 Medical Devices Recommended for Approval
October 26, 2009
- NHI Price Revision Rate, Policy to Be Proposed by Panel under Health Minister
October 26, 2009
- NEW PRODUCTS／Yakuban Tape 60 mg to Be Launched in December
October 26, 2009
- JMA Demands Increases in Medical Fees
October 26, 2009
- 32nd JSH Annual Scientific Meeting
October 26, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…